array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Becton, Dickinson and Company" ["slug"]=> string(37) "4601d-us-becton-dickinson-and-company" ["logo"]=> NULL ["description"]=> NULL ["address_street"]=> string(11) "1 Becton Dr" ["address_place"]=> string(14) "Franklin Lakes" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1897-02-28" ["website_domain"]=> string(6) "bd.com" ["website_url"]=> string(18) "https://www.bd.com" ["industry_codes"]=> array(2) { [0]=> string(46) "Surgical and Medical Instruments and Apparatus" [1]=> string(60) "Orthopedic, Prosthetic, and Surgical Appliances and Supplies" } ["employee_count"]=> int(1500) ["article_count"]=> int(417) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(61) "Becton, Dickinson and Company (BDX) Declined on 2024 Guidance" ["snippet_en"]=> string(293) "Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. During the fourth quarter, equity markets ended the year on a high note, with the S&P 500 achieving an 11.7% increase." ["url"]=> string(83) "https://finance.yahoo.com/news/becton-dickinson-company-bdx-declined-052333036.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4c3b1a59-d4f1-4399-922d-fdc2e1f3d030" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-02-05" ["categories"]=> array(7) { [0]=> string(12) "Stock Market" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(9) "Investors" [3]=> string(18) "General Investment" [4]=> string(22) "Sustainable Investment" [5]=> string(19) "Investment Requests" [6]=> string(24) "Quarterly/Annual Figures" } } [1]=> array(7) { ["title_en"]=> string(50) "BD reports 2.6% revenue increase in Q1 fiscal 2024" ["snippet_en"]=> string(139) "Becton, Dickinson and Company (BD) reported a revenue of $4.7bn for Q1 of fiscal 2024, marking a 2.6% increase from the last year's $4.5bn." ["url"]=> string(69) "https://www.medicaldevice-network.com/news/bd-revenue-q1-fiscal-2024/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9cb0737a-90b3-467c-bcc6-e3b343cb28d0" ["source"]=> string(25) "medicaldevice-network.com" ["publication_date"]=> string(10) "2024-02-02" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [2]=> array(7) { ["title_en"]=> string(74) "Becton, Dickinson and Company (NYSE:BDX) Updates FY 2024 Earnings Guidance" ["snippet_en"]=> string(192) "Becton, Dickinson and Company (NYSE:BDX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 12.700-13.000 for the period, compared to the consensus estimate of 12.840." ["url"]=> string(80) "https://www.marketbeat.com/instant-alerts/nyse-bdx-earnings-guidance-2024-01-30/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/fcc5ea78-060d-4200-8c03-1164f98b410d" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-30" ["categories"]=> array(5) { [0]=> string(12) "Stock Market" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(13) "Credit Rating" [3]=> string(24) "Stock Research & Ratings" [4]=> string(24) "Quarterly/Annual Figures" } } [3]=> array(7) { ["title_en"]=> string(82) "Becton, Dickinson and Company (BDX) Set to Announce Quarterly Earnings on Thursday" ["snippet_en"]=> string(242) "Becton, Dickinson and Company (NYSE:BDX – Get Free Report) is scheduled to announce its earnings results before the market opens on Thursday, February 1st. Analysts expect the company to announce earnings of $2.39 per share for the quarter." ["url"]=> string(124) "https://www.defenseworld.net/2024/01/25/becton-dickinson-and-company-bdx-set-to-announce-quarterly-earnings-on-thursday.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4bfeb520-8e49-46fe-8bd5-9e4fc6c1a9a3" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-01-25" ["categories"]=> array(5) { [0]=> string(15) "Market Movement" [1]=> string(12) "Stock Market" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(24) "Stock Research & Ratings" [4]=> string(24) "Quarterly/Annual Figures" } } [4]=> array(7) { ["title_en"]=> string(67) "Becton, Dickinson and Company Q4 Profit Decreases, misses estimates" ["snippet_en"]=> string(149) "(RTTNews) - Becton, Dickinson and Company (BDX) announced earnings for fourth quarter that decreased from last year and missed the Street estimates." ["url"]=> string(97) "https://www.nasdaq.com/articles/becton-dickinson-and-company-q4-profit-decreases-misses-estimates" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-11-09" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [5]=> array(7) { ["title_en"]=> string(66) "Becton, Dickinson and Company Q3 Profit Increases, beats estimates" ["snippet_en"]=> string(197) "WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) reported a profit for its third quarter that increased from the same period last year and beat the Street estimates.The company's earnings" ["url"]=> string(134) "https://www.finanznachrichten.de/nachrichten-2023-08/59750899-becton-dickinson-and-company-q3-profit-increases-beats-estimates-020.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3d1199ad-c93b-459b-adb5-1240fc221577" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-08-03" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [6]=> array(7) { ["title_en"]=> string(57) "BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised" ["snippet_en"]=> string(230) "Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $2.86 for the second quarter of fiscal 2023, up 2.9% year over year. The figure surpassed the Zacks Consensus Estimate by 4%." ["url"]=> string(86) "https://www.nasdaq.com/articles/bd-bdx-q2-earnings-surpass-estimates-fy23-view-revised" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-05-04" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [7]=> array(7) { ["title_en"]=> string(66) "Becton, Dickinson and Company Q2 Profit Increases, beats estimates" ["snippet_en"]=> string(150) "(RTTNews) - Becton, Dickinson and Company (BDX) reported earnings for its second quarter that increased from last year and beat the Street estimates." ["url"]=> string(98) "https://www.nasdaq.com/articles/becton-dickinson-and-company-q2-profit-increases-beats-estimates-0" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-05-04" ["categories"]=> array(2) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" } } [8]=> array(7) { ["title_en"]=> string(65) "Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results" ["snippet_en"]=> string(162) "PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care..." ["url"]=> string(136) "https://www.globenewswire.com/news-release/2023/02/14/2607411/0/en/Embecta-Corp-Reports-First-Quarter-Fiscal-2023-Financial-Results.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/dcf8f3e7-2359-4a92-a388-43b84e57c8c8" ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2023-02-14" ["categories"]=> array(1) { [0]=> string(24) "Quarterly/Annual Figures" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(44) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(26) } [2]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [3]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(20) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(20) } [6]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(15) } [8]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(15) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(13) } [11]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(12) } [12]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(11) } [14]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(8) } [16]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(14) "Product Recall" ["count"]=> int(6) } [20]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(6) } [21]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(5) } [22]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(5) } [23]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(5) } [24]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [25]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(4) } [26]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(4) } [27]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(4) } [28]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(4) } [29]=> array(2) { ["name"]=> string(19) "Green & Responsible" ["count"]=> int(4) } } } 4601d-us-becton-dickinson-and-company

Becton, Dickinson and Company

Location

New Jersey

Founded

1897-02-28

Website

https://www.bd.com

Articles

417 Articles

Category

Surgical and Medical Instruments and Apparatus

Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Description

Articles

Becton, Dickinson and Company (BDX) Declined on 2024 Guidance

2024-02-05 (yahoo.com)

Becton, Dickinson and Company (BDX) Declined on 2024 Guidance

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. During the fourth quarter, equity markets ended the year on a high note, with the S&P 500 achieving an 11.7% increase.

Read more
BD reports 2.6% revenue increase in Q1 fiscal 2024

2024-02-02 (medicaldevice-network.com)

BD reports 2.6% revenue increase in Q1 fiscal 2024

Becton, Dickinson and Company (BD) reported a revenue of $4.7bn for Q1 of fiscal 2024, marking a 2.6% increase from the last year's $4.5bn.

Read more
Becton, Dickinson and Company (NYSE:BDX) Updates FY 2024 Earnings Guidance

2024-01-30 (marketbeat.com)

Becton, Dickinson and Company (NYSE:BDX) Updates FY 2024 Earnings Guidance

Becton, Dickinson and Company (NYSE:BDX) updated its FY 2024 earnings guidance. The company provided EPS guidance of 12.700-13.000 for the period, compared to the consensus estimate of 12.840.

Read more
Becton, Dickinson and Company (BDX) Set to Announce Quarterly Earnings on Thursday

2024-01-25 (defenseworld.net)

Becton, Dickinson and Company (BDX) Set to Announce Quarterly Earnings on Thursday

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) is scheduled to announce its earnings results before the market opens on Thursday, February 1st. Analysts expect the company to announce earnings of $2.39 per share for the quarter.

Read more
Becton, Dickinson and Company Q4 Profit Decreases, misses estimates

2023-11-09 (nasdaq.com)

Becton, Dickinson and Company Q4 Profit Decreases, misses estimates

(RTTNews) - Becton, Dickinson and Company (BDX) announced earnings for fourth quarter that decreased from last year and missed the Street estimates.

Read more
Becton, Dickinson and Company Q3 Profit Increases, beats estimates

2023-08-03 (finanznachrichten.de)

Becton, Dickinson and Company Q3 Profit Increases, beats estimates

WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX) reported a profit for its third quarter that increased from the same period last year and beat the Street estimates.The company's earnings

Read more
BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised

2023-05-04 (nasdaq.com)

BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $2.86 for the second quarter of fiscal 2023, up 2.9% year over year. The figure surpassed the Zacks Consensus Estimate by 4%.

Read more
Becton, Dickinson and Company Q2 Profit Increases, beats estimates

2023-05-04 (nasdaq.com)

Becton, Dickinson and Company Q2 Profit Increases, beats estimates

(RTTNews) - Becton, Dickinson and Company (BDX) reported earnings for its second quarter that increased from last year and beat the Street estimates.

Read more
Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results

2023-02-14 (globenewswire.com)

Embecta Corp. Reports First Quarter Fiscal 2023 Financial Results

PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care...

Read more

Newsletter subscription